Table 2 Comparison between all studied patients’ data before and after treatment
All patients | Before treatment | After treatment (at SVR12) | p-value | |
|---|---|---|---|---|
No. = 100 | No. = 100 | |||
TG (mg/dl) | Mean ± SD | 101.68 ± 29.85 | 88.64 ± 26.53 | 0.000 |
Range | 53–199 | 17–145 | ||
S. chol. (mg/dl) | Mean ± SD | 124.17 ± 38.55 | 114.25 ± 35.21 | 0.000 |
Range | 55–199 | 50–188 | ||
HDL (mg/dl) | Mean ± SD | 36.15 ± 9.63 | 48.97± 5.63 | 0.000 |
Range | 20–55 | 32–70 | ||
LDL (mg/dl) | Mean ± SD | 81.79 ± 21.43 | 88.09 ± 21.80 | 0.000 |
Range | 44–136 | 32–141 | ||
s.cr. (mg/dl) | Mean ± SD | 0.89 ± 0.13 | 0.94 ± 0.15 | 0.000 |
Range | 0.7–1.17 | 0.4–1.4 | ||
AFP (ng/ml) | Mean ± SD | 14.94 ± 2.29 | 12.11 ± 2.05 | 0.000 |
Range | 10.5–22 | 9–20 | ||
HbA1c (%) | Mean ± SD | 5.73 ± 0.23 | 5.40 ± 0.24 | 0.000 |
Range | 5–6 | 5–6 | ||